Peroxynitrite (ONOO ) is a highly reactive oxidant species produced by the reaction of the free radicals superoxide (O 2 *~) and nitric oxide (NO'). Here we report a marked increase in nitrotyrosine (NT), a marker of peroxynitrite, in islet cells from NOD mice developing spontaneous autoimmune diabetes. By using specific antibodies and immunohistochemical methods, we found that NT-positive cells were significantly more frequent in islets from acutely diabetic NOD mice (22 ± 6% ) than in islets from normoglycemic NOD mice (7 ± 1%) and control BALB/c mice (2 ± 1%). The NT + cells in islets were identified to be macrophages and also P-cells. Most of the p-cells in islets from acutely diabetic NOD mice were NT + (73 ± 8%), whereas significantly fewer p-cells were NT + in islets from normoglycemic NOD mice (18 ± 4%) and BALB/c mice (5 ± 1%). Also, the percentage of p-cells in islets from NOD mice (normoglycemic and diabetic) correlated inversely with the frequency of NT + P-cells. This study demonstrates for the first time that peroxynitrite, a reaction product of superoxide and nitric oxide, is formed in pancreatic islet p-cells of NOD mice developing autoimmune diabetes. This suggests that both oxygen and nitrogen free radicals contribute to P-cell destruction in IDDM via peroxynitrite formation in the islet p-cells. Diabetes 46:907-911, 1997
exposure to various products of these cells, such as cytokines, oxygen radicals, and nitric oxide (3) (4) (5) (6) . There is abundant in vitro evidence that islet p-cells are sensitive to injury mediated by oxygen radicals (3, 4) and nitric oxide (5, 6) . Furthermore, the proinflammatory cytokines interleukin-ip (IL-ip), tumor necrosis factor-a (TNF-a), and 7-interferon (TFN-7) are cytotoxic to P-cells via mechanisms that may involve the production of oxygen radicals and/or nitric oxide in the islet P-cells (3) (4) (5) . For example, intra-islet release of IL-1 by passenger macrophage activation in vitro leads to the expression of inducible nitric oxide synthase (iNOS) within the p-cells and to consequent impaired insulin secretion (7) .
Recently, evidence has been obtained for the production of nitric oxide in pancreatic islets in situ in conjunction with IDDM development. Thus, iNOS has been demonstrated by immunohistochemistry in islets of diabetes-prone BB rats (8) and in islet-infiltrating macrophages of NOD mice with cyclophosphamide-enhanced diabetes (9) . Also, we have identified p-cells, as well as macrophages, to be sources of nitric oxide production in islets of diabetes-prone NOD mice (10) . Evidence for oxygen free radical production in pancreatic islets in conjunction with autoimmune diabetes development, however, is lacking.
Peroxynitrite (ONOO~) is a highly reactive oxidant species produced by the combination of the free radicals nitric oxide (NO*) and superoxide (O 2 '~) (11, 12) . The production of peroxynitrite has been demonstrated in various forms of shock and inflammation (13) (14) (15) (16) (17) . Current evidence suggests that peroxynitrite is a more potent oxidant and cytotoxic mediator than nitric oxide or superoxide alone (12, 17, 18) . Recently, peroxynitrite was reported to be cytotoxic to both rat and human islet cells in vitro (19) . The aim of the present study was to determine if peroxynitrite is formed in pancreatic islet p-cells undergoing autoimmune destruction in vivo.
RESEARCH DESIGN AND METHODS
Animals. Female NOD and BALB/c mice (9 weeks of age) were purchased from Taconic Farms (Germantown, NY). The mice were housed and fed under specific pathogen-free conditions and were cared for according to the guidelines of the Canadian Council on Animal Care. Female NOD mice of this colony develop pancreatic islet infiltration by cells of the immune system (insulitis) beginning at ~6 weeks of age. This is followed by islet p-cell destruction and IDDM beginning at -12 weeks of age, and diabetes incidence is -80% by 30 weeks of age. The NOD mice were monitored daily for the appearance of diabetes by urine glucose testing (Testape, Eli Lilly, Toronto, Ontario), and diabetes onset was diagnosed by the presence of glucosuria and a tail vein blood glucose >12 mmol/1 measured on a Companion 2 glucose sensor (Medisense, Cambridge, MA). The mice were killed by sodium pentobarbital overdose, and pancreases were removed from 9 female NOD mice within 24 h of diabetes onset (acutely diabetic; ages 12-16 weeks), 15 normoglycemic (prediabetic) female NOD mice (age 12 weeks), and 12 normoglycemic (diabetes-resistant) female BALB/c mice (age 12 weeks). Islets were isolated from the pancreas of each animal and processed separately. Islet cell preparations. Pancreatic islets were isolated by stationary collagenase digestion of the pancreas and Ficoll density-gradient purification, followed by handpicking of the isolated islets (20) . The islets were dispersed into single cells by incubation at 37°C for 10 min in Ca 2+ -and Mg
2+
-free phosphate-buffered saline (PBS) containing 0.2 mg/ml EDTA, followed by syringe injection through progressively narrower-gauge needles. The islet cells were washed twice in PBS, then fixed with 4% paraformaldehyde in PBS for 10 min, and washed twice in PBS; the fixed cells (50 X 10 3 cells in 10 ul) were placed on glass slides coated with aptex (Sigma, St. Louis, MO). The slides were stored at -70°C until cell staining was performed.
Two-color immunostaining of cell surface antigens and intracellular nitrotyrosine (NT). The slides with fixed cells attached were thawed, and the cells were rapidly treated with 1% paraformaldehyde in PBS at 4°C for 10 min. They were then washed twice in cold PBS, and 0.3% H 2 O 2 in PBS was added for 10 min. The cells were next incubated in PBS containing 10% normal goat serum and 1.5% bovine serum albumin for 3 h at room temperature to block nonspecific binding before antibody staining. The following monoclonal antibodies (mAbs) were used to stain different cell surface antigens: a rat mAb to the total leukocyte common antigen, CD45/T200 (mAb Ly-5, IgG2, Cedarlane Laboratories), 10 ug/ml in 10% rabbit serum; a rat mAb to the macrophage antigen, Mac-1 (mAb Ml/70.15.1, IgG2, Cedarlane), 10 ug/ml in 10% rabbit serum; and a mouse mAb to an islet (3-cell ganglioside antigen (mAb R2D6, IgM, provided by Dr. R. Alejandro, Miami, FL), 20 ug/ml in PBS (21) . The cells were incubated with these mAbs separately overnight at 4°C in a humidity chamber. Parallel incubations were carried out with isotype-matched control mAbs (Cedarlane). The cells were then washed thoroughly in PBS for 30 min, and the second antibodies (Zymed Laboratories, San Francisco, CA) were added for 15 min at room temperature. For cells incubated with Mac-1 as the first antibody, the second antibody was a biotinylated goat anti-rat mouse-adsorbed IgG (Dimension Laboratories, Mississauga, Ontario, Canada) diluted 1:50 in 2% normal mouse serum. For cells incubated with R2D6 as the first antibody, the second antibody was a biotinylated goat anti-mouse IgM (Cedarlane) diluted 1:20 in 0.3% normal mouse serum. After incubations with second antibodies, the cells were washed in PBS, incubated with streptavidin-alkaline phosphatase conjugate (Zymed) for 15 min at room temperature, washed in PBS, and incubated with a 1:1 dilution of alkaline phosphatase Fastblue (Vector Laboratories, Burlingame, CA) for 3-5 min until cell surface staining (blue) reached a maximum intensity as observed under the microscope. Then, to reveal intracellular NT by immunostaining with an antibody to NT, plasma cell membranes were permeabilized by incubating the cells in 1.5% saponin (Sigma) in PBS (PBS saponin) for 30 min at room temperature. The cells were then washed in PBS saponin, and PBS saponin was present during all subsequent antibody incubations and between washes. Endogenous peroxidase in the cells was blocked by incubation in PBS saponin with 1% H 2 O 2 for 45 min at room temperature, then in PBS saponin with 10% normal rabbit serum in 1.5% bovine serum albumin for 2 h at room temperature. The cells were then incubated for 1.5 h at room temperature, separately, with each of the following antibodies: 10 ug/ml of an affinity-purified rabbit anti-NT antibody raised by immunizing rabbits with peroxynitrite-treated keyhole limpet hemocyanin (provided by Dr. J.S. Beckman, University of Alabama at Birmingham) (22) ; rabbit isotype-matched antibody (IgG, Cedarlane), 10 ug/ml; and a mixture of anti-NT antibody (10 ug/ml, final concentration) and 3-nitro-L-tyrosine (Aldrich Chemicals, Milwaukee, WI) (10 mmol/1, final concentration) in 0.1 mol/1 PBS to neutralize the anti-NT antibody. The cells were then washed three times in PBS saponin and incubated for 15 min at room temperature with a second antibody, biotinylated goat anti-rabbit IgG (Zymed), diluted 1:100 in PBS saponin with 2% normal mouse serum. The cells were then washed five times in PBS saponin for 30 min and incubated for 15 min at room temperature in PBS saponin diluted 1:1 with streptavidin-peroxidase conjugate (Histostain-SP kit, Zymed). The cells were then washed five times in PBS saponin, and the biotinylated second antibody step was repeated, followed by incubation with the enzyme conjugate as described above. These two successive cycles were necessary to amplify the specific NT staining. Finally, the substrate chromogen 3-amino 9-ethylcarbazole was added, and this provided an intense red intracytoplasmic staining of the NT antigen-antibody-enzyme complex. The stained cells were mounted on the slides by the addition of Crystal Mount (Biomeda, Foster City, CA). 
Validation of the two-color immunostaining method to identify NT
Data are means ± SE for 11 incubations. Cells from a mouse macrophage cell line (RAW 264.7) were cultured for 48 h in medium without and with LPS (10 ug/ml) + IFN-7 (100 U/ml) to activate the macrophages. The cells were then stained with one or more of the antibodies (immunoglobulins) indicated (see METHODS).
10% heat-activated fetal calf serum (Gibco BRL, Burlington, Ontario, Canada) without and with 10 ug/ml lipopolysaccharide (LPS) (Sigma) and 100 U/ml murine IFN-7 (Genentech, South San Francisco, CA). The cells were then washed twice in PBS, fixed with 4% paraformaldehyde in PBS for 10 min, and washed twice in PBS; the fixed cells (50 x 10 3 cells in 10 ul) were placed on glass slides coated with aptex (Sigma) and stored at -70°C until cell staining was performed. Table 1 shows that RAW 264.7 cells stained positively for NT (NT + ) only after activation with LPS plus IFN-7 (75 ± 6% NT + cells). Furthermore, cell staining was specific for NT, since a control antibody stained only 6 ± 2% of the cells and since neutralization of anti-NT antibody by 10 mmol/1 NT blocked cell staining by the antibody (only 3 ± 2% of the cells stained NT + ). Most of the RAW 264.7 cells that were activated by LPS plus IFN-7 were identified as macrophages by staining with an antibody to a macrophage cell surface antigen, Mac-1 (68 ± 7% Mac-1 + cells), and these activated macrophages all expressed NT, as demonstrated by staining with both anti-NT and antimacrophage antibodies (70 ± 4% NT + Mac-1 + cells). Quantification of the two-color immunostained islet cells. Islet cell preparations were stained in duplicate with anti-macrophage (Mac-1), anti-3-cell (R2D6), or isotype-matched control antibodies, then with anti-NT antibody, control antibody, or anti-NT antibody neutralized with excess NT. A total of 6,000 cells were scored blindly by two independent observers using light microscopy. NT-expressing cells were identified by red intracellular staining. The phenotype of the NT + islet cell (macrophage or (3-cell) was identified by blue staining of the cell surface after incubation with the corresponding cellspecific antibody. An NT + cell line (RAW 264.7 cells activated with LPS plus IFN-7; Table 1 ) was run in parallel with the islet cell samples to confirm assay sensitivity. Statistical analysis. Data are presented as means ± SE, and statistical comparisons between groups were made by analysis of variance followed by Tukey-Kramer's test.
RESULTS
Cell composition of islets from diabetic and normoglycemic mice. Islet cell composition was analyzed in islets isolated from three groups of mice (Table 2 ). These groups represented mice with different degrees of pancreatic islet infiltration by mononuclear leukocytes (insulitis), as we have previously reported (23) . Thus, acutely diabetic female NOD mice had severe insulitis (63 ± 2% of islet cells were leukocytes) and normoglycemic (prediabetic) female NOD mice had moderate insulitis (39 ± 2% of islet cells were leukocytes), whereas islets of BALB/c mice, which do not develop diabetes, contained few leukocytes (8 ± 3% of islet cells). Also, macrophages were most abundant in islets of diabetic NOD mice. These different degrees of insulitis resulted in corresponding degrees of (3-cell destruction. Thus, (3-cells were Data are means ± SE for the number of mice in each group. Islets were isolated from pancreases of three different groups of female mice, ages 12-16 weeks: acutely diabetic NOD mice, normoglycemic NOD mice, and normoglycemic BALB/c mice. The isolated islets from the pancreas of each animal were processed separately. The islets were dispersed into single cells, and the cell types were identified by immunohistochemical staining with specific antibodies to leukocytes (CD45 + cells), macrophages (Mac-1 + cells), and p-cells (R2D6 + cells), and an antibody to NT was used to identify NT-expressing (NT + ) cells. Less than 1% of cells were stained with isotype-matched antibodies that served as controls for the anti-leukocyte and anti-macrophage antibodies (rat IgG2), the anti-p-cell antibody (mouse IgM), and the anti-NT antibody (rabbit IgG); also none of the cells were stained after incubation with anti-NT antibody that had been neutralized with 10 mmol/1 NT. *P < 0.01, t P < 0.05 when compared to values for BALB/c, normoglycemic mice; tP < 0.01, §P < 0.05 when compared to values for NOD normoglycemic mice. markedly reduced in islets from diabetic NOD mice (only 13 ± 1% were p-cells) and moderately reduced in islets from normoglycemic NOD mice (22 ± 2% were P-cells), by comparison to the cell composition of islets from control BALB/c mice (55 ± 3% were p-cells). NT-expressing cells were significantly more frequent in islets from diabetic NOD mice (22 ± 6% of islet cells) than in islets from normoglycemic NOD mice (7 ± 1% of islet cells) and BALB/c mice (2 ± 1% of islet cells).
Identification of NT-expressing cells in islets.
NTexpressing (NT + ) cells in islets were identified to be macrophages and p-cells by two-color immunohistochemistry ( in islets from the different groups of mice were then compared ( Table 2) . Islets from diabetic NOD mice had the most NT + macrophages (7 ± 1% of total islet cells and 67 ± 7% of the macrophage fraction) compared with islets from normoglycemic NOD mice (3 ± 1% of total islet cells and 57 ± 8% of the macrophage fraction) and BALB/c mice (<1% of total islet cells and 29 ± 9% of the macrophage fraction). Importantly, islets from diabetic NOD mice had the most NT* p-cells (11 ± 1% of total islet cells and 73 ± 8% of the p-cell fraction) compared with islets from normoglycemic NOD mice (3 ± 1% of total islet cells and 18 ± 4% of the p-cell fraction) and BALB/c mice (1 ± 1% of total islet cells and 2 ± 1% of the pcell fraction). Furthermore, the percentage of p-cells in islets from NOD mice (normoglycemic and diabetic) correlated inversely with the frequency of NT + p-cells (Fig. 2) . DISCUSSION IDDM in NOD mice, as in humans, is associated with infiltration of the pancreatic islets by mononuclear cells of the immune system (macrophages and lymphocytes), termed insulitis, and this is followed by destruction of the insulin-producing islet P-cells. Oxygen free radicals and nitric oxide produced by cytokine-activated macrophages and/or p-cells themselves have been implicated as mediators of islet pcell destruction in autoimmune diabetes (3) (4) (5) (6) (7) (8) (9) . Recently, we reported that iNOS is expressed in islet-infiltrating macrophages as well as in p-cells of prediabetic NOD mice (10) . This suggested that nitric oxide is formed by both macrophages and P-cells in islets of NOD mice developing autoimmune diabetes. The present study supports this conclusion because we found that both macrophages and p-cells in NOD islets express peroxynitrite, a reaction product of superoxide and nitric oxide (11, 12) . Peroxynitrite was detected in the islet cells by using immunohistochemical techniques and an antibody to NT, a specific marker for nitration of tyrosine residues on proteins by peroxynitrite (22) . Furthermore, we found a marked increase in NT-expressing p-cells in NOD mice in association with p-cell destruction and diabetes development. Thus, islets of acutely diabetic female NOD mice had the most NT + cells (73% of p-cells were NT + ), followed by islets of normoglycemic (prediabetic) female NOD mice (18% of p-cells were NT + ), then islets of female BALB/c mice, which do not develop diabetes (only 2% of p-cells were NT + ). Because NT is produced by peroxynitrite-induced nitration of tyrosine residues on proteins (22), our findings imply that peroxynitrite-induced protein damage is occurring in the majority of p-cells at the onset of diabetes in NOD mice. This interpretation is supported by the finding that the percentage of P-cells in islets from NOD mice (normoglycemic and diabetic) correlated inversely with the frequency of NT + P-cells.
Further support for a cytotoxic role for peroxynitrite in autoimmune diabetes comes from a recent report that acute exposure of human and rat islet cells to peroxynitrite in vitro resulted in islet cell death via necrosis (19) . In the latter study, peroxynitrite caused an early impairment in glucose oxidation and DNA strand breaks in islet cells (19) . Since peroxynitrite-induced DNA strand breakage is known to lead to poly-ADP-ribose synthetase (PARS) activation, NAD consumption, reduced ATP generation, and ultimately cell death (24, 25) , it is conceivable that peroxynitrite might be cytotoxic to islet P-cells, at least in part, via PARS activation. PARS has previously been proposed to act as a mediator of P-cell cytotoxicity in response to streptozocin (26) and nitric oxide exposure (27) (28) (29) . Furthermore, peroxynitrite appears to play a key role in the development of DNA single-strand breakage and PARS activation in a variety of cells exposed to nitric oxide donor compounds or to streptozocin (25) .
In conclusion, the present data demonstrate the in vivo formation of peroxynitrite in pancreatic islets in conjunction with destruction of the insulin-producing islet p-cells and IDDM development in NOD mice. Because peroxynitrite is a reaction product of superoxide and nitric oxide, this implicates both oxygen free radicals (superoxide) and nitric oxide as mediators of islet p-cell damage in autoimmune diabetes. Furthermore, since both islet-infiltrating macrophages and islet p-cells were sites of peroxynitrite formation, it appears that p-cells may be damaged by peroxynitrite produced by macrophages infiltrating the islets as well as by peroxynitrite produced by the p-cells themselves. Peroxynitrite formation in islet cells (both macrophages and P-cells) likely involves actions of proinflammatory cytokines on these cells; however, this remains to be demonstrated, as do the precise mechanisms by which peroxynitrite leads to p-cell dysfunction and death. Nevertheless, the present findings suggest that peroxynitrite may be a cytotoxic mediator in autoimmune diabetes; therefore, experimental approaches to IDDM prevention might include neutralization of peroxynitrite.
